Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
PCT No. PCT/US93/01135 Sec. 371 Date Oct. 5, 1993 Sec. 102(e) Date Oct. 5, 1993 PCT Filed Feb. 9, 1993 PCT Pub. No. WO93/16107 PCT Pub. Date Aug. 19, 1993.This invention provides a novel improved alpha interferon composition characterized by high specific activity, a purity of greater than 95% and w...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MEI-JUNE LIAO DOUGLAS TESTA KATALIN FERENCZ-BIRO ABBAS RASHIDBAIGI MARIO DIPAOLA MANISHA PADHYE |
| description | PCT No. PCT/US93/01135 Sec. 371 Date Oct. 5, 1993 Sec. 102(e) Date Oct. 5, 1993 PCT Filed Feb. 9, 1993 PCT Pub. No. WO93/16107 PCT Pub. Date Aug. 19, 1993.This invention provides a novel improved alpha interferon composition characterized by high specific activity, a purity of greater than 95% and which upon use in humans is further characterized by a substantial reduction in side effects normally associated with alpha interferon compositions. Also provided is a method for large scale production of the composition from human peripheral blood leukocytes. This alpha interferon composition may be used therapeutically in the treatment of cancers and diseases of the immune system and/or viral etiology. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU674306BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU674306BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU674306BB23</originalsourceid><addsrcrecordid>eNqNi0EKAjEMRWfjQtQ75AKCOKJrRxTd63qIbUqrbRPSjuDtHcQDuPoP3vvT5nFJovwiCxjFI4RcSR0pZzCchEuoYWTMFhJVzxYcK4RaYLzZwXytU07gh4QZhDSIJ8UI98hjHml4snlXKvNm4jAWWvx21sDpeD2clyTcUxE0lKn2-9t2t2lX265bt38kH50jQdY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Improved alpha interferon composition and method for its production from human peripheral blood leukocytes</title><source>esp@cenet</source><creator>MEI-JUNE LIAO ; DOUGLAS TESTA ; KATALIN FERENCZ-BIRO ; ABBAS RASHIDBAIGI ; MARIO DIPAOLA ; MANISHA PADHYE</creator><creatorcontrib>MEI-JUNE LIAO ; DOUGLAS TESTA ; KATALIN FERENCZ-BIRO ; ABBAS RASHIDBAIGI ; MARIO DIPAOLA ; MANISHA PADHYE</creatorcontrib><description>PCT No. PCT/US93/01135 Sec. 371 Date Oct. 5, 1993 Sec. 102(e) Date Oct. 5, 1993 PCT Filed Feb. 9, 1993 PCT Pub. No. WO93/16107 PCT Pub. Date Aug. 19, 1993.This invention provides a novel improved alpha interferon composition characterized by high specific activity, a purity of greater than 95% and which upon use in humans is further characterized by a substantial reduction in side effects normally associated with alpha interferon compositions. Also provided is a method for large scale production of the composition from human peripheral blood leukocytes. This alpha interferon composition may be used therapeutically in the treatment of cancers and diseases of the immune system and/or viral etiology.</description><edition>5</edition><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>1996</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961219&DB=EPODOC&CC=AU&NR=674306B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961219&DB=EPODOC&CC=AU&NR=674306B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MEI-JUNE LIAO</creatorcontrib><creatorcontrib>DOUGLAS TESTA</creatorcontrib><creatorcontrib>KATALIN FERENCZ-BIRO</creatorcontrib><creatorcontrib>ABBAS RASHIDBAIGI</creatorcontrib><creatorcontrib>MARIO DIPAOLA</creatorcontrib><creatorcontrib>MANISHA PADHYE</creatorcontrib><title>Improved alpha interferon composition and method for its production from human peripheral blood leukocytes</title><description>PCT No. PCT/US93/01135 Sec. 371 Date Oct. 5, 1993 Sec. 102(e) Date Oct. 5, 1993 PCT Filed Feb. 9, 1993 PCT Pub. No. WO93/16107 PCT Pub. Date Aug. 19, 1993.This invention provides a novel improved alpha interferon composition characterized by high specific activity, a purity of greater than 95% and which upon use in humans is further characterized by a substantial reduction in side effects normally associated with alpha interferon compositions. Also provided is a method for large scale production of the composition from human peripheral blood leukocytes. This alpha interferon composition may be used therapeutically in the treatment of cancers and diseases of the immune system and/or viral etiology.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1996</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0EKAjEMRWfjQtQ75AKCOKJrRxTd63qIbUqrbRPSjuDtHcQDuPoP3vvT5nFJovwiCxjFI4RcSR0pZzCchEuoYWTMFhJVzxYcK4RaYLzZwXytU07gh4QZhDSIJ8UI98hjHml4snlXKvNm4jAWWvx21sDpeD2clyTcUxE0lKn2-9t2t2lX265bt38kH50jQdY</recordid><startdate>19961219</startdate><enddate>19961219</enddate><creator>MEI-JUNE LIAO</creator><creator>DOUGLAS TESTA</creator><creator>KATALIN FERENCZ-BIRO</creator><creator>ABBAS RASHIDBAIGI</creator><creator>MARIO DIPAOLA</creator><creator>MANISHA PADHYE</creator><scope>EVB</scope></search><sort><creationdate>19961219</creationdate><title>Improved alpha interferon composition and method for its production from human peripheral blood leukocytes</title><author>MEI-JUNE LIAO ; DOUGLAS TESTA ; KATALIN FERENCZ-BIRO ; ABBAS RASHIDBAIGI ; MARIO DIPAOLA ; MANISHA PADHYE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU674306BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1996</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>MEI-JUNE LIAO</creatorcontrib><creatorcontrib>DOUGLAS TESTA</creatorcontrib><creatorcontrib>KATALIN FERENCZ-BIRO</creatorcontrib><creatorcontrib>ABBAS RASHIDBAIGI</creatorcontrib><creatorcontrib>MARIO DIPAOLA</creatorcontrib><creatorcontrib>MANISHA PADHYE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MEI-JUNE LIAO</au><au>DOUGLAS TESTA</au><au>KATALIN FERENCZ-BIRO</au><au>ABBAS RASHIDBAIGI</au><au>MARIO DIPAOLA</au><au>MANISHA PADHYE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Improved alpha interferon composition and method for its production from human peripheral blood leukocytes</title><date>1996-12-19</date><risdate>1996</risdate><abstract>PCT No. PCT/US93/01135 Sec. 371 Date Oct. 5, 1993 Sec. 102(e) Date Oct. 5, 1993 PCT Filed Feb. 9, 1993 PCT Pub. No. WO93/16107 PCT Pub. Date Aug. 19, 1993.This invention provides a novel improved alpha interferon composition characterized by high specific activity, a purity of greater than 95% and which upon use in humans is further characterized by a substantial reduction in side effects normally associated with alpha interferon compositions. Also provided is a method for large scale production of the composition from human peripheral blood leukocytes. This alpha interferon composition may be used therapeutically in the treatment of cancers and diseases of the immune system and/or viral etiology.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU674306BB2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE |
| title | Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A39%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MEI-JUNE%20LIAO&rft.date=1996-12-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU674306BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |